A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and Blood

GD2, a disialoganglioside, is present on the surface of most neuroblastomas, as well as on some other cancers, such as melanoma and osteogenic sarcoma. The anti-GD2 antibody ch14.18 (dinutuximab) has an FDA-registered indication for use as maintenance therapy for high-risk neuroblastoma with cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Keyel, Michelle E., Furr, Kathryn L., Kang, Min H., Reynolds, C. Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573805/
https://www.ncbi.nlm.nih.gov/pubmed/37834874
http://dx.doi.org/10.3390/jcm12196223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573805/
https://www.ncbi.nlm.nih.gov/pubmed/37834874
http://dx.doi.org/10.3390/jcm12196223

Ejemplares similares